 - Patients with chronic GVHD diagnosed within 3 years after hematopoietic stem cell transplant HSCT for any disease, with any graft, and any conditioning regimen with at least one manifestation secondary to fibrosis, including: sclerodermatous skin changes, dry mouth, dry eye, esophageal strictures, or vaginal GVHD 